Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Ory Rouvio"'
Autor:
Muhammed Iraqi, Avishay Edri, Yariv Greenshpan, Oron Goldstein, Noa Ofir, Priyanka Bolel, Muhammad Abu Ahmad, Miri Zektser, Kerry S. Campbell, Ory Rouvio, Roi Gazit, Angel Porgador
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 9, p 4717 (2022)
Multiple Myeloma (MM) is a devastating malignancy that evades immune destruction using multiple mechanisms. The NKp44 receptor interacts with PCNA (Proliferating Cell Nuclear Antigen) and may inhibit NK cells’ functions. Here we studied in vitro th
Externí odkaz:
https://doaj.org/article/f163f63997ee48638e6fe3a7bfd223c8
Publikováno v:
Perspective of Recent Advances in Medical Research Vol. 11 ISBN: 9788119039722
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d982b5467779a5359d802bc4ee6cf7f0
https://doi.org/10.9734/bpi/pramr/v11/4838e
https://doi.org/10.9734/bpi/pramr/v11/4838e
Autor:
Chezi Ganzel, Svetlana Trestman, Shai Levi, Moshe E. Gatt, Noa Lavi, Iuliana Vaxman, Ory Rouvio, Hila Magen, Eyal Lebel, Netanel A. Horowitz, Merav Leiba, Tamar Tadmor, Katrin Herzog Tzarfati, Celia Surio, Shay Yeganeh, Nagib Dally, Irit Avivi, Yael C. Cohen
Publikováno v:
Leukemialymphoma.
Solitary plasmacytoma (SP) is a rare plasma cell dyscrasia. In this retrospective multicenter study, 68 SP patients were included. Compared to solitary extramedullary plasmacytoma (SEP), patients with solitary bone plasmacytoma (SBP) were younger (57
Autor:
Yael C Cohen, Moshe E Gatt, Efrat Luttwak, Noa Lavi, Chezi Ganzel, Evgeni Chubar, Ory Rouvio, Iuliana Vaxman, Oren Pasvolsky, Mouna Ballan, Tamar Tadmor, Anatoly Nemets, Osnat Jarchowsky, Olga Shvetz, Ofer Shpilberg, Najib Dally, Merav Leiba, Assaf Weiner, Mor Zada, Shuang-Yin Wang, Chamutal Gur, Noa Lowenton-Spier, Liron Goor-Porges, Ido Amit, Irit Avivi
Publikováno v:
Blood. 140:4426-4427
Autor:
Moshe E. Gatt, Ofer Shpilberg, Noa Lavi, Eyal David, Adi Moshe, Shuang-Yin Wang, Irit Avivi, Chamutal Gur, Assaf Weiner, Baoguo Li, Oren Pasvolsky, Mor Zada, Shir Shlomi-Loubaton, Tamar Tadmor, Meirav Laiba, Chamutal Bornstein, Efrat Luttwak, Chezi Ganzel, Anatoly Nemets, Yael C Cohen, Ory Rouvio, Osnat Jarchowcky-Dolberg, Mouna Ballan, Najib Dally, Iuliana Vaxman, Olga Shvetz, Ido Amit, Evgeni Chubar
Publikováno v:
Nat Med
Multiple myeloma (MM) is a neoplastic plasma-cell disorder characterized by clonal proliferation of malignant plasma cells. Despite extensive research, disease heterogeneity within and between treatment-resistant patients is poorly characterized. In
Autor:
Itai Levi, Vitaly Dizengof, Gil Ben-Yakov, Ohad Etzion, Alexander Fich, Ilana R. Azulay Chertok, Avital Blum, Uri Greenbaum, Ory Rouvio
Publikováno v:
European Journal of Gastroenterology & Hepatology. 32:569-574
Background & aims After the rise of lymphoma incidence in the 1990's, there is a paucity of epidemiologic studies describing the characteristics of primary gastrointestinal non-Hodgkin's lymphoma (PGIL). This epidemiologic survey aims to identify rec
Autor:
Ory Rouvio, Lev Shvidel, Michal Inbar, Andrei Braester, Uri Greenbaum, Mona Yuklea, Osnat Bairey, Neta Goldschmidt, Ariel Aviv, Najib Dally, Rosa Ruchlemer, Ilana Levy, Aaron Polliack, Tamar Tadmor, Adir Shaulov, Yair Herishanu, Riva Fineman
Publikováno v:
Leukemia Research. 82:24-28
Background Major advances in the treatment of patients with hairy cell leukemia (HCL) have been made following the introduction of purine analogues. The major significant short-term toxicity of cladribine therapy are neutropenia and neutropenic fever
Autor:
Moshe E. Gatt, Efrat Luttwak, Svetlana Trestman, Irit Avivi, Tamar Tadmor, Kreiniz Natalia, Noam Benyamini, Eyal Lebel, Noa Lavi, Celia Suriu, Moshe Mittelman, Netanel A. Horowitz, Ory Rouvio, Yael C Cohen, Mika Geva
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(11)
Background Lenalidomide and ixazomib maintenance improve long-term outcomes in newly diagnosed multiple myeloma (NDMM) patients. However, there is less evidence to support bortezomib (BTZ) maintenance therapy, and real-life data on maintenance are sc
Classification of Solitary Plasmacytoma, Is it more Intricate than Presently Suggested? A Commentary
Publikováno v:
Journal of Cancer
A query regarding the definition and the classification of solitary plasmacytoma is apparently still pending. The clinical course, the response to treatment and the propensity to progress to plasma cell myeloma, are all a function of the classificati
Autor:
Iuliana Vaxman, Merav Leiba, Moshe E. Gatt, Baoguo Li, Yael C Cohen, Ofer Shpilberg, Ory Rouvio, Noa Lavi, Tamar Tadmor, Anatoly Nemets, Osnat Jarchowcky Dolberg, Oren Pasvolsky, Efrat Lutwak, Chamutal Bornstein, Adi Moshe, Nagib Deli, Yevgeny Chober, Irit Avivi, Ido Amit, Shir Shlomi, Olga Shvetz, Eyal David, Mouna Ballan, Shuang-Yin Wang, Mor Zada, Assaf Weiner, Chezi Ganzel
Publikováno v:
Blood. 136:19-20
Substantial progress in the treatment of Multiple Myeloma (MM) extends survival for many patients (Pts), though most Pts eventually relapse and become therapy refractory. Patients with induction resistant multiple myeloma (IRMM), either primary refra